Development of angiogenesis inhibitors for cancer therapy
The preclinical evaluation of angiogenesis inhibitors
Markers of tumor angiogenesis : clinical applications in prognosis and anti-angiogenic therapy
Angiogenic factors as tumor markers
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents
An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action
Matrix metalloproteinase inhibitors
Somatostatin analogs : angiogenesis inhibitors with novel mechanisms of action